Risk Stratification for Sudden Death and Arrhythmias: A Role for Gadolinium-Enhanced CMR

Andrew E Arai; Andrew J Bradley; Arlene Sirajuddin

doi:10.1016/j.jacc.2020.11.014

Risk Stratification for Sudden Death and Arrhythmias: A Role for Gadolinium-Enhanced CMR

J Am Coll Cardiol. 2021 Jan 5;77(1):42-44. doi: 10.1016/j.jacc.2020.11.014.

Authors

Andrew E Arai¹, Andrew J Bradley², Arlene Sirajuddin²

Affiliations

¹ National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA. Electronic address: araia@nih.gov.
² National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA.

PMID: 33413939
DOI: 10.1016/j.jacc.2020.11.014

No abstract available

Keywords: cardiovascular magnetic resonance; gray zone mass; implantable cardioverter-defibrillator; peri-infarct mass; primary prevention; ventricular fibrillation; ventricular tachycardia.

Publication types

Editorial
Comment

MeSH terms

Arrhythmias, Cardiac / diagnosis
Coronary Artery Disease*
Death, Sudden
Fibrosis
Gadolinium*
Humans
Risk Assessment

Substances

Gadolinium